Skip to content

Comparative Evaluation of External Chest Wall Fixator Treatment Effectiveness in Patients With Rib Fractures

Comparative Evaluation of External Chest Wall Fixator Treatment Effectiveness in Patients With Rib Fractures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06448078
Enrollment
34
Registered
2024-06-07
Start date
2020-10-21
Completion date
2022-02-17
Last updated
2024-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rib Fractures, Trauma

Keywords

rib fracture, external chest wall fixator, trauma

Brief summary

This study aimed to investigate the effect of external chest wall fixator on patients' pain level, complication development and hospital stay in patients with rib fractures.Patients who were admitted due to trauma and had serial rib fractures were evaluated. Standard treatment was applied to the control group. External chest wall fixator was applied to the case group in standard treatment. Pain levels of the patients, development of complications and duration of hospitalization were recorded.

Detailed description

Basis of treatment for rib fractures is pain control and physiotherapy. External chest wall fixators may provide a new approach as part of multimodal treatment. This study aimed to investigate the effect of external chest wall fixator on patients' pain level, complication development and hospital stay in patients with rib fractures. Patients who were admitted due to trauma and had serial rib fractures were evaluated. There were 14 patients in case group and 20 in control group. Standard treatment was applied to the control group. External chest wall fixator was applied to the case group in addition to standard treatment. Pain levels of the patients, development of complications and duration of hospitalization were recorded. Pain levels of the patients were evaluated using the Visual Analogue Scale and the pain level was scored between 0 and 10.

Interventions

DEVICEExternal chest wall fixator

External chest wall fixator is applied in the form of external bonding to the rib fracture area

Sponsors

Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open label

Intervention model description

Within the scope of the study, external fixator will be applied to 14 patients in the form of external bonding to the rib fracture area for 15 days, along with standard medical treatment. Standard medical treatment will be applied to 20 patients and these patients will constitute the control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with serial rib fractures after trauma * Patients without extrathoracic pathology

Exclusion criteria

* Patients with less than 3 rib fractures * Patients with extrathoracic injuries * Patients with bilateral rib fractures * Patients with flail chest * Patients with hemothorax or pneumothorax requiring drainage with tube thoracostomy at first admission

Design outcomes

Primary

MeasureTime frameDescription
Pain Level3 monthsPain level of patients on the 10th day, 1st month and 3rd month (Visual Analogue Pain Scale (VAS) will be used to assess pain level.Pain level will be scored between 1 and 10.Higher scores represent worse outcomes.)
Complications3 monthsNumber of participants who developed complications
Hospital Stay3 monthsDuration of hospital stay of patients (days)

Countries

Turkey (Türkiye)

Participant flow

Participants by arm

ArmCount
Case Group
External chest wall fixator will be applied to the rib fracture area in the case group External chest wall fixator: External chest wall fixator is applied in the form of external bonding to the rib fracture area
14
Control Group
No intervention will be made to the control group
20
Total34

Baseline characteristics

CharacteristicControl GroupTotalCase Group
Age, Continuous52.50 years
STANDARD_DEVIATION 13.8
55.38 years
STANDARD_DEVIATION 16.51
59.50 years
STANDARD_DEVIATION 19.55
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Turkey
20 participants34 participants14 participants
Sex: Female, Male
Female
4 Participants8 Participants4 Participants
Sex: Female, Male
Male
16 Participants26 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 20
other
Total, other adverse events
0 / 140 / 20
serious
Total, serious adverse events
0 / 140 / 20

Outcome results

Primary

Complications

Number of participants who developed complications

Time frame: 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Case GroupComplications2 Participants
Control GroupComplications8 Participants
Primary

Hospital Stay

Duration of hospital stay of patients (days)

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Case GroupHospital Stay2.00 dayStandard Deviation 0.784
Control GroupHospital Stay2.70 dayStandard Deviation 0.979
Primary

Pain Level

Pain level of patients on the 10th day, 1st month and 3rd month (Visual Analogue Pain Scale (VAS) will be used to assess pain level.Pain level will be scored between 1 and 10.Higher scores represent worse outcomes.)

Time frame: 3 months

Population: first month pail level

ArmMeasureValue (MEAN)Dispersion
Case GroupPain Level1.79 score on a scaleStandard Deviation 0.8
Control GroupPain Level2.85 score on a scaleStandard Deviation 1.53

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026